Subscribe



Latest Headlines

Thu 23 Mar 17

PD breaking news – Sigma cracks $100 million in “underlying profit”


Pharmacy Daily

Sales to Sigma-branded pharmacies up 8.2% following heavy investment in national retail brands.


Thu 23 Mar 17

PSNZ awards new Fellowships


THE Pharmaceutical Society of New Zealand (PSNZ) has awarded three new Fellowships to "outstanding candidates who have made and continue to make an exceptional contribution to the profession".


Thu 23 Mar 17

Pharmacy key for flu vax


ALMOST all Australians (93%)have identified pharmacy as the place to receive their influenza vaccine this season, citing access, cost and convenience as the biggest motivators, the Pharmacy Guild of Australia reports.


Wed 22 Mar 17

AFT seals NovoTears deal


AFT Pharmaceuticals yesterday confirmed a new licensing agreement with German specialty pharmaceutical company to distribute NovaTears in Australia and New Zealand.


Wed 22 Mar 17

Compounding feedback


THE Pharmaceutical Society of Australia is seeking submissions on its revised Compounding Standard, yesterday releasing a consultation paper which is open to feedback until 18 Apr 2017.


Tue 21 Mar 17

NatRUM alerts to med risks


Pharmacy Daily

JUST 18% of Australians are aware of the National Return and Disposal of Unwanted Medicines (NatRUM) scheme, with most people simply putting unused drugs into their household rubbish.


Tue 21 Mar 17

EpiPen auto-injector recall


ALPHAPHARM, in consultation with the Therapeutic Goods Administration (TGA), has announced it is recalling four batches of EpiPen 300 microgram adrenaline injection syringe auto-injectors, due to the potential failure to activate or the need to apply increased force to activate the device.


Mon 20 Mar 17

SHPA transparency call


THE Society of Hospital Pharmacists of Australia (SHPA) has supported the concept of full and open transparency on the part of the Therapeutic Goods Administration (TGA) in its submission to the TGA relating to 'Expedited pathways for prescription medicines'.


Mon 20 Mar 17

$30m Yasmin patent payout


BAYER will receive more than $30 million in damages and interest after receiving a favourable judgement in its long-running case with Generic Health over patent infringement for its Yasmin and YAZ oral contraceptives.


Fri 17 Mar 17

More pharmacy vax feedback


Pharmacy Daily

PHARMACY Daily readers continue to react to comments by Professor Robert Booy of the Influenza Specialists Group (PD Tue), who earlier this week claimed pharmacist flu vaccinations were using old stock not formulated for 2017 strains.


View More Pharmacy News Subscribe to the Newsletter